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Abstract
Objective: To evaluate the effects of different hemostatic agents upon the outcome of periapical surgery. 
Design: A retrospective study was made of patients subjected to periapical surgery between 2006-2009 with the 
ultrasound technique and using MTA as retrograde filler material. We included patients with a minimum follow-
up of 12 months, divided into two groups according to the hemostatic agent used: A) dressings impregnated in 
anesthetic solution with adrenalin; or B) aluminum chloride paste (Expasyl™). Radiological controls were made 
after 6 and 12 months, and on the last visit. The global evolution scale proposed by von Arx and Kurt (1999) was 
used to establish the outcome of periapical surgery.
Results: A total of 96 patients (42 males and 54 females) with a mean age of 40.7 years were included. There were 
50 patients in the aluminum chloride group and 46 patients in the anesthetic solution with vasoconstrictor group. 
No significant differences were observed between the two groups in terms of outcome after 12 months - the suc-
cess rate being 58.6% and 61.7% in the anesthetic solution with vasoconstrictor and aluminum chloride groups, 
respectively (p>0.05).
Conclusion: The outcome after 12 months of follow-up was better in the aluminum chloride group than in the 
anesthetic solution with vasoconstrictor group, though the difference was not significant. 
Key words: Aluminum chloride, bleeding control, hemostasis, periapical surgery, outcome.
MA Peñarrocha-Diago, Maestre-Ferrín L, Peñarrocha-Oltra D, von Arx 
T, Peñarrocha-Diago M. �n� uence of hemostatic agents upon the out-
come of periapical surgery: Dressings with anesthetic and vasoconstric-
tor or aluminum chloride. Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 
(2):e272-8. 
http://www.medicinaoral.com/medoralfree01/v18i2/medoralv18i2p272.pdf
Article Number: 18002          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.18002
http://dx.doi.org/doi:10.4317/medoral.18002
Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 (2):e272-8.                                                                                                                                              Hemostatic agents and apical surgery outcome
e273
Introduction
Many factors can in�uence the outcome of periapical 
surgery. In this context, adequate bleeding control is es-
sential for the success of periapical surgery, since it im-
proves visualization of the surgical site, minimizes the 
operating time, and is a requirement for the insertion of 
most retrograde filling materials (1,2). 
Different agents and techniques have been used to se-
cure hemostasis in periapical surgery. Bone wax has 
been used for many years and is easy to handle, though 
remaining traces of this material can cause adverse tis-
sue reactions (3). Similar problems have been observed 
with ferric sulfate: when not completely eliminated 
from the surgical site, it gives rise to foreign body re-
actions that complicate healing (4). Vickers et al. (5) 
evaluated the hemostatic efficacy and cardiovascular ef-
fects of ferric sulfate and of cotton pellets impregnated 
with racemic adrenaline. Both agents afforded surgical 
hemostasis, and there were no significant changes in 
the systemic cardiovascular parameters with either of 
them. In a similar study, Vy et al. (6) concluded that 
collagen sponges impregnated with adrenaline affords 
excellent bleeding control, with no evident changes in 
either blood pressure or heart rate. 
Von Arx et al. (7) introduced the use of Expasyl™ (Pierre 
Rolland, Merignac, France) for securing hemostasis in 
periapical surgery. This is a paste containing aluminum 
chloride and kaolin, and is normally used to produce 
gingival retraction (8,9). In an experimental study, von 
Arx et al. (7) compared the hemostatic efficacy and the 
tissue reactions of bone wax, ferric sulfate, aluminum 
chloride, and a combination of aluminum chloride and 
ferric sulfate. Expasyl™ alone or in combination with 
ferric sulfate was found to be the most effective agent, 
and the in�ammatory reactions were limited to the 
bone defects, with no spread to the surrounding tissues. 
Jensen et al. (10) used the same study design to compare 
the effects of 5 hemostatic techniques: Expasyl™ + Sta-
sis®, Expasyl™ + Stasis® + bone crypt freshening with 
a drill, Spongostan®, Spongostan® + adrenaline, and 
electrocautery. The most effective methods for reducing 
bleeding were Expasyl™ + Stasis® and electrocautery, 
but adverse tissue reactions were observed (necrotic 
bone, in�ammatory cells, absence of bone repair). Such 
tissue damage was not recorded when the superficial 
bone layer was eliminated with rotary instruments.
A number of studies have been published involving dif-
ferent materials used to secure hemostasis in periapical 
surgery, though none have correlated the outcome of 
periapical surgery to the hemostatic agent used.
The present study was carried out to compare the out-
come of periapical surgery when using two different he-
mostatic agents: dressings impregnated with anesthetic 
solution containing a vasoconstrictor (adrenaline), and 
aluminum chloride paste (Expasyl™).
Material and Methods
-Sample selection
A retrospective study was carried out in the Oral Surgery 
Unit (Valencia University Medical and Dental School, 
Valencia, Spain) covering the period between October 
2006 and March 2009 and including the patients sub-
jected to periapical surgery with the ultrasound tech-
nique, using MTA (ProRoot®, Dentsply, USA) as ret-
rograde filling material. The study was approved by the 
local Ethics Committee, and all patients gave informed 
consent to participation in the study. 
In all cases dressings impregnated in anesthetic solu-
tion with vasoconstrictor, or aluminum chloride paste, 
were used for securing hemostasis, and the minimum 
follow-up period was 12 months. Specifically, we used 
dressings impregnated in anesthetic solution with va-
soconstrictor (4% articaine with adrenaline 1:100,000)
(Inibsa, Lliça de Vall, Barcelona, Spain) in the patients 
treated between October 2006 and December 2007, 
and aluminum chloride (Expasyl™, Produits Dentaires 
Pierre Rolland, Merignac, France) in the patients treat-
ed between January 2008 to March 2009.
In the patients with periapical lesions measuring over 
20 mm in diameter, with tunnel lesions rupturing the 
vestibular and lingual cortical layers, or with apicomar-
ginal defects with complete vestibular cortical loss, 
hemostasis was secured with dressings impregnated in 
anesthetic solution with vasoconstrictor, due to the dif-
ficulty of eliminating the remaining traces of Expasyl™ 
in such situations. In these cases we always used bone 
regeneration techniques, and decided to exclude the 
patients from the study, since they all belonged to the 
adrenalin with vasoconstrictor group.
We likewise excluded those patients in which no hemos-
tasis material had been used (9 patients). The resulting 
initial study sample consisted of 123 patients, divided 
into two groups according to the hemostatic agent used: 
A) dressings impregnated in anesthetic solution with 
adrenalin (55 patients); or B) aluminum chloride paste 
(Expasyl™)(68 patients).
Eight patients were excluded due to incomplete study 
protocols (one in the dressings group and 7 in the Expa-
syl™ group), 14 because of a lack of follow-up (3 in the 
dressings group and 11 in the Expasyl™ group), and 5 
patients in the dressings group in which bone regenera-
tion techniques had been used (3 patients with periapi-
cal lesions measuring over 20 mm in diameter, one with 
a periapical lesion rupturing the vestibular and lingual 
cortical layers, and one patient with an apicomarginal 
defect and complete vestibular cortical loss).
The final study sample thus consisted of 96 patients: 46 
belonging to the dressings with anesthetic and vasocon-
strictor group and 50 to the Expasyl™ group.
-Surgical technique
All the operations were made by the same surgeon 
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(MPD). Locoregional and infiltrating anesthetic tech-
niques were used with 4% articaine and adrenaline 
1:100,000 (Inibsa, Lliça de Vall, Barcelona, Spain). In-
trasulcular incisions were made with one or two vertical 
releasing incisions for raising triangular or trapezoidal 
mucoperiosteal �aps. Ostectomy was performed using a 
rounded 0.27 mm tungsten carbide drill (Jota, Switzer-
land) under abundant irrigation with saline solution. The 
minimum apical resection needed to access the apexes 
was made, followed by apical curettage. The cavity was 
prepared for retrograde filling using a Piezon Master® 
400 ultrasound instrument (EMS, Electro Medical Sys-
tems, S.A., Switzerland) at full power with diamond-
surfaced ultrasound tips for periapical surgery. To fa-
cilitate the procedure, use was made of a Medi Pack Pal 
endoscope (Farol Store and Co., Tuttlingen, Germany) 
and Moeller® Dental 300 surgical microscope (Möller-
Wedel �nternational, Bedel, Germany). Bone cavity 
drying and bleeding control was carried out in group 
A by means of small sterile dressings impregnated with 
anesthetic solution with adrenaline as vasoconstrictor 
at a concentration of 1:100,000 (Inibsa, Lliça de Vall, 
Barcelona, Spain), placed within the bone crypt. Dry 
dressings were then placed and pressure was applied for 
two minutes, after which all the dressings except the 
first impregnated dressing were removed, and the surgi-
cal procedure was continued – removing the impregnat-
ed dressing before saline irrigation and suturing (Fig. 
1). In group B use was made of ExpasylTM (Expasyl, 
Produits Dentaires Pierre Rolland, Merignac, France) 
applied during two minutes (Fig. 2). Finally, ProRoot® 
(Dentsply, USA) mineral trioxide aggregate (MTA) ret-
rograde filling material was prepared, inserted and con-
densed, following the indications of the manufacturer. 
In the patients in which Expasyl™ was used, the bone 
crypt was refreshed with a rounded drill under abun-
dant irrigation before suturing. Suturing was carried out 
with Tevdek® non-reabsorbable sutures (Deknatel®, 
Tele�ex®, Athlone, �reland) composed of polyester fib-
ers coated with polytetra�uoroethylene (PTFE).
In all cases the following medication was prescribed 
in the week after surgery: amoxicillin 500 mg with 
clavulanic acid 125 mg every 8 hours during 6 days; 
ibuprofen 600 mg every 8 hours during 4 days; 0.12% 
chlorhexidine gluconate rinses three times a day during 
7 days; and paracetamol 500 mg upon demand in the 
event of important pain.
-Radiographic evaluation
Periapical and panoramic X-rays were obtained with an 
XMIND® intraoral system (Groupe Satelec - Pierre Rol-
land®, France), together with digital panoramic X-rays 
(OP100®, Instrumentarium Imaging, Tuusula, Finland).
Radiographic controls were made immediately after 
surgery, after 6 and 12 months, and on occasion of the 
subsequent annual control visits. The months elapsed 
from surgery to final control (counting to the last visit of 
each patient) or until failure were recorded for calculat-
ing mean patient follow-up.
Fig. 1. Periapical surgery of an upper second premolar using dressings impregnated with anesthetic and vaso-
constrictor as hemostatic agent. A) Preoperative clinical view. B) Periapical X-ray view showing a periapical 
radiotransparent area in relation to the apex of the second premolar. C) Intraoperative view following ostec-
tomy. D) View of the bone cavity after curettage of the periapical lesion. E) Hemostasis with dressing impreg-
nated with anesthetic and vasoconstrictor. F) Retrograde filling with MTA. G) View of retrograde filling after 
eliminating the excess MTA and impregnated dressing. H) Radiological control after 12 months of follow-up.
A B C
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Fig. 2. Upper left premolars periapical surgery using Expasyl™ to control bleeding. A) Preoperative clinical view. B) Periapical X-ray view 
showing a periapical radiotransparent area between the apexes of both premolars. C) Periapical lesion after ostectomy. D) View of the bone 
cavity after curettage of the periapical lesion. E) Expasyl™ inserted in the bone crypt and allowed to act during two minutes. F) The cavity is 
irrigated with sterile saline solution to remove the excess Expasyl™. G) Retrograde cavities prepared in both teeth. H) Retrograde filling with 
MTA. I) Periapical radiological control after 12 months of follow-up.
A B C
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-Scales of success
The outcome of periapical surgery was assessed based 
on the global evolution scale proposed by von Arx and 
Kurt (11), which combines clinical and radiological cri-
teria. Outcome was classified as: 1) success: when bone 
regeneration was ≥ 90% and the clinical and pain score 
was 0 (on a scale of 0-3); 2) improvement: when bone re-
generation was 50-90% and the clinical and pain score 
was 0; and 3) failure: when bone regeneration was < 
50% or there were clinical symptoms.
-Data collection and statistical analysis
A clinical history was compiled for all patients, fol-
lowing a previously established protocol - recording 
the personal antecedents of interest, collecting all the 
clinical and radiographic data of the patients in detail, 
and registering the pre-, intra- and postoperative cha-
racteristics.
The SSPS version 15 statistical package for MS Win-
dows was used for analyzing the data. In each study 
group we performed a descriptive analysis of all the 
variables (gender, age and area of the periapical le-
sions), checking that there were no differences between 
the two groups for any of these variables. The outcomes 
of periapical surgery after 6 and 12 months and at the 
final control, in each group, were compared using the 
chi-squared test, with a statistical significance level of 
p<0.05. �n all cases the necessary tests for confirming 
the applicability of the different statistical techniques 
were carried out.
Results
The study comprised a total of 96 patients (42 males and 
54 females) with a mean age of 40.7 years (range 12-67). 
The Expasyl™ group consisted of 50 patients (with 81 
apicoectomized teeth, 110 treated roots and 125 treated 
canals), while the anesthetic solution with vasocon-
strictor group comprised 46 patients (with 58 apicoec-
tomized teeth, 78 treated roots and 91 treated canals). 
The mean duration of follow-up was 17.1 months (range 
1-41). In the anesthetic solution with vasoconstrictor 
group the mean duration of follow-up was 18.6 months 
(range 1-41), versus 16.6 months (range 1-26 months) 
in the Expasyl™ group. There were no significant dif-
ferences in the duration of follow-up between the two 
groups of patients (t = 1.12; p = 0.26).
Table 1 shows the mean age and gender distribution of 
the patients in each group, together with the data referred 
to the area of the periapical lesions. There were no sig-
nificant differences between the two groups in terms of 
mean age, gender distribution or periapical lesion size.
The global outcome in each group after 6 and 12 months 
and on occasion of the final control, as established from 
the global evolution scale of von Arx and Kurt (11), is 
reported in table 2. The periapical surgery success rate 
at last control was 62.5% in the Expasyl™ group and 
58.6% in the group treated with dressings impregnated 
with anesthetic solution and vasoconstrictor. The out-
come of periapical surgery was better in the Expasyl™ 
group than in the anesthetic solution with vasoconstric-
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Table 1. Mean age, gender distribution and periapical lesion size in each group.
Agente Hemos-
tático
Age Gender Lesion area before 
surgery (mm2)
Lesion area after surgery 
(mm2)
Mean t p Females Males X2 p Mean t p Mean t p
Dressings im-
pregnated with 
anesthetic and 
vasoconstrictor
41.3 0.45 0.65 26 20 0.00 0.96 44.3 1.74 0.08 49.1 -0.32 0.75
Expasyl™ 40.1       28       22   34.6   51.9
6 months Dressings with 
vasoconstrictor
Expasyl™ Total χ2 p
Global assessment Success 42.9 % 37.2 % 39.6 % 0.44 0.8
Improvement 46.4 % 51.3% 49.3 %
Failure 10.7 % 11.5 % 11.2 %
12 months Dressings with 
vasoconstrictor
Expasyl™ Total χ2 p
Global assessment Success 58.6 % 61.7 % 60.4 % 2.85 0.24
Improvement 32.8 % 34.6 % 33.8 %
Failure 8.6 % 3.7 % 5.8 %
Last control Dressings with 
vasoconstrictor
Expasyl™ Total χ2 p
Global assessment Success 58.6 % 62.5 % 60.9 % 2.27 0.32
Improvement 27.6 % 31.3 % 29.7 %
Failure 13.8 % 6.2 % 9.4 %
Table 2. Outcome of periapical surgery after 6 and 12 months, and at the last control visit, according to the criteria of von Arx and 
Kurt (11).
tor group after 12 months of follow-up and on occasion 
of the final control, though the differences were not sta-
tistically significant.
Discussion
The outcome of periapical surgery can differ consid-
erably from one study to another, depending on the 
patient inclusion criteria used, the scales employed to 
score success, and the duration of follow-up (12). In the 
present study we used the criteria of von Arx and Kurt 
for assessing the outcome of periapical surgery (11). Ac-
cording to Peñarrocha et al. (13) and Ortega-Sanchez et 
al. (14), this is the scale offering the best information, 
and which agrees best with the rest of the scales. The 
minimum duration of follow-up needed to determine 
the outcome of periapical surgery has been established 
as 12 months (15-17).
On occasion of the control visit after 12 months, 60.4% 
of the teeth showed treatment success, 33.8% improve-
ment, and 5.8% failure. At the final control (after an av-
erage of 17.4 months of follow-up), 60.9% of the teeth 
showed treatment success, 29.7% improvement, and 
9.4% failure. The success rates reported by other au-
thors also using ultrasound and MTA, independently 
of the hemostatic material used, range from 74-92% 
(18-24), though the study designs and success scoring 
criteria differ among the publications. Most of them 
(18-22,24) followed the criteria established by Rud et al. 
(16) and Molven et al. (25), calculating the success rates 
by combining the number of fully healed teeth and in-
completely healed teeth (scar), and regarding them all as 
healed cases. In order to compare our results with those 
of the above authors, we summed the percentages of 
success and improvement to obtain a healing rate after 
12 months of 94.2%, which falls within the described 
ranges. Tsesis et al. (26) published a metaanalysis quan-
tifying the outcomes of periapical surgery and study-
ing the in�uence of different factors upon treatment 
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outcome. These authors obtained a periapical surgery 
success rate after one year of follow-up of 91.6%, which 
coincides with our own findings and with those of von 
Arx et al. in their metaanalysis (91.4% for teeth filled 
with MTA)(27).
Only one study to date (23) has correlated the outcome 
of periapical surgery to the use of hemostatic agents. In 
order to control bleeding of the bone crypt, the authors 
used dressings impregnated with adrenaline or ferric 
sulfate. The evaluation was made according to whether 
either material had been used or not, without differenti-
ating the results obtained with each of them individual-
ly. The authors found that the use of a hemostatic agent 
is not predictive of the outcome of periapical surgery. 
Von Arx et al. (20) used aluminum chloride (Expa-
syl™) and/or ferric sulfate to secure hemostasis during 
periapical surgery of 194 human teeth, with a success 
rate of 90.2%, though the in�uence of the hemostatic 
agent upon the outcome of surgery was not analyzed.
�n our study we found no significant differences in the 
outcome of periapical surgery between the two groups. 
In the control performed after 6 months, the outcome 
was seen to be poorer in the Expasyl™ group, though 
not significantly so, while after 12 months the opposite 
situation was observed (i.e., outcome was comparatively 
better in the Expasyl™ group). The evolution between 6 
and 12 months after surgery was more favorable in the 
Expasyl™ group than in the group treated with dress-
ings impregnated with anesthetic solution and vaso-
constrictor. This could be explained by the presence of 
remaining traces of Expasyl™ - despite having favored 
bleeding within the bone cavity - which could have de-
layed bone formation during the first months. However, 
the more positive course seen in this same group over 
the subsequent months was probably due to better qual-
ity retrograde fillings resulting from the excellent field 
dryness and visibility conditions afforded by Expasyl™, 
and which would minimize bacterial filtration between 
the periapex and root canal system. Nevertheless, since 
patient assignment to each group was not randomized 
(this being a retrospective study), the comparatively 
more favorable results obtained in the Expasyl™ group 
may have been a mere coincidence or could have been 
in�uenced by the surgeon learning curve. Randomized, 
controlled prospective studies involving large sample 
sizes are therefore needed to more firmly establish the 
effects of Expasyl™ upon the outcome of periapical 
surgery. The healing percentages (summing success 
and improvement) after 12 months were 96.3% in the 
Expasyl™ group and 91.4% in the group treated with 
dressings impregnated with anesthetic solution and va-
soconstrictor. These figures are slightly higher than the 
90.2% healing rate mentioned above, corresponding to 
the study of von Arx et al. (20) using Expasyl™ and/or 
ferric sulfate to control bleeding.
It has been seen that aluminum chloride produces in-
�ammatory reactions in the soft tissues when used for 
gingival retraction (28,29). In the study of von Arx et al. 
(7) in rabbits, Expasyl™ alone or in combination with 
ferric sulfate induced foreign body reactions with evi-
dence of an in�ammatory tissue response three and 12 
weeks after placement. Moreover, in contrast to the con-
trol sites, bone formation was minimal and delayed. The 
authors therefore recommended cleaning the surgical 
wound with a curette and refreshing the bone walls with 
a rounded drill before wound closure. Jensen et al. (10) 
noted that adverse reactions to Expasyl™ did not occur 
if the traces of the paste were eliminated from the bone 
crypt with rotary instruments. In our study we favored 
bleeding within the bone cavity before suturing, and 
the teeth in the Expasyl™ group had a better prognosis 
than those belonging to the anesthetic solution with va-
soconstrictor group after 12 months of follow-up and on 
occasion of the last control visit (nonsignificant differ-
ences) – though not so at the first control after 6 months. 
It is therefore possible that foreign body reactions to the 
paste were not entirely avoided by our procedure, re-
sulting in slower healing in the Expasyl™ group in the 
first few months. Further studies are needed to deter-
mine whether the surgical improvements and facilities 
afforded by Expasyl™ effectively contribute to improve 
the outcome of periapical surgery over the long term.
Conclusion
The outcome after 12 months of follow-up was better 
in the Expasyl™ group than in the anesthetic solution 
with vasoconstrictor group, though the difference was 
not significant.
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